Good Manufacturing Practices for Drug Products (GUI-001) Updated
Advocacy & Action
Notice to Stakeholders Regarding the AHA/PHA Entry on the Cosmetic Ingredient Hotlist
Batteries now managed under individual producer responsibility framework
Participate in RPRA’s Proposed 2020 Registry Fees Consultation
Release of draft (step 2) ICH guidance: Q3C(R8): Impurities: Residual solvents
Various Publications under the Chemicals Management Plan
Environment & Climate Change Canada’s Risk Assessment Publications Plan for July-September 2020
European Commission Data on Prostaglandins
